Scholarlink

Background <p>Increasing evidence suggests that the gut-brain axis plays a critical role in cognitive and behavioral development. However, clinical evidence supporting cognitive benefit of probiotics and postbiotics in typically developing children remains limited. This study evaluated the effects of a postbiotic formulation containing heat-killed <i>Bifidobacterium longum</i> KABP-042 and <i>Lactiplantibacillus plantarum</i> KABP-051 on brain-related outcomes in school-aged children.</p> Methods <p>This study randomly allocated 60 typically developing children (aged 8–10 years) to receive either a daily jelly containing heat-killed KABP-042 and KABP-051 (5 × 10<sup>9</sup> cells each) or a placebo for 12 weeks. The primary endpoints were changes in working memory (digit span), inhibitory control (Go/No-go task), and cognitive flexibility measured by the Stroop test. Secondary endpoints included autonomic nervous system (ANS) activity, emotional and behavioral assessment, and gut microbiota composition.</p> Results <p>Participants who received the postbiotic intervention demonstrated significantly higher accuracy (<i>p</i> = 0.019) and lower error rates (<i>p</i> = 0.004) in the incongruent condition of the Stroop test at 12 weeks compared to placebo, while reaction time was unchanged. No significant between-group differences were observed in working memory, inhibitory control, ANS activity, emotional and behavioral outcomes, and gut microbiota composition, although changes in beta diversity were significantly greater in the placebo group (<i>p</i> = 0.049).</p> Conclusions <p>Twelve weeks of postbiotic intervention was associated with enhanced accuracy-related Stroop task performance, particularly in the incongruent condition, in typically developing children, whereas other cognitive outcomes were unaffected. These preliminary findings suggest that supplementation with KABP-042 and KABP-051 may influence selected aspects of cognitive task performance in children. Further investigation into the underlying mechanisms and long-term outcomes is warranted.</p> Trial registration <p>This study was registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR; ID: UMIN000058366).</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Effects of heat-killed Bifidobacterium longum KABP-042 and Lactiplantibacillus plantarum KABP-051 on cognitive performance in typically developing school-aged children: a placebo-controlled, randomized double-blind parallel-group trial

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年8月5日

查看全文
  • Naoki Arai,
  • Shinichi Honda,
  • Yuji Tominaga,
  • Jinko Sawashita,
  • Kyoko Tanaka,
  • Isao Nagaoka,
  • Takahiro Ueda

摘要

Background

Increasing evidence suggests that the gut-brain axis plays a critical role in cognitive and behavioral development. However, clinical evidence supporting cognitive benefit of probiotics and postbiotics in typically developing children remains limited. This study evaluated the effects of a postbiotic formulation containing heat-killed Bifidobacterium longum KABP-042 and Lactiplantibacillus plantarum KABP-051 on brain-related outcomes in school-aged children.

Methods

This study randomly allocated 60 typically developing children (aged 8–10 years) to receive either a daily jelly containing heat-killed KABP-042 and KABP-051 (5 × 109 cells each) or a placebo for 12 weeks. The primary endpoints were changes in working memory (digit span), inhibitory control (Go/No-go task), and cognitive flexibility measured by the Stroop test. Secondary endpoints included autonomic nervous system (ANS) activity, emotional and behavioral assessment, and gut microbiota composition.

Results

Participants who received the postbiotic intervention demonstrated significantly higher accuracy (p = 0.019) and lower error rates (p = 0.004) in the incongruent condition of the Stroop test at 12 weeks compared to placebo, while reaction time was unchanged. No significant between-group differences were observed in working memory, inhibitory control, ANS activity, emotional and behavioral outcomes, and gut microbiota composition, although changes in beta diversity were significantly greater in the placebo group (p = 0.049).

Conclusions

Twelve weeks of postbiotic intervention was associated with enhanced accuracy-related Stroop task performance, particularly in the incongruent condition, in typically developing children, whereas other cognitive outcomes were unaffected. These preliminary findings suggest that supplementation with KABP-042 and KABP-051 may influence selected aspects of cognitive task performance in children. Further investigation into the underlying mechanisms and long-term outcomes is warranted.

Trial registration

This study was registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR; ID: UMIN000058366).